Legend Biotech Corporation Sponsored ADR (LEGN) shares ended the last trading session 18.4% higher at $25.07. The jump came on an impressive volume with a higher-than-average number of shares changing ...

Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Tuesday, May 12, 2026, to review first quarter ...

Legend, like Kelonia, develops and manufactures cell therapies to treat life-threatening diseases, particularly cancer. ・Legend is best known for Carvykti, a CAR-T treatment for relapsed or refractory ...

Legend Biotech Corporation looks like a J&J acquisition target as Carvykti sales surge and Phase 2 data impress. Click for ...

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a ...

Legend Biotech Corp. (NASDAQ:LEGN) is one of the 10 Stocks With Double-Digit Returns. Legend Biotech soared for a 5th ...

Investors in Legend Biotech Corp (Symbol: LEGN) saw new options begin trading this week, for the May 2025 expiration. One of the key data points that goes into the price an option buyer is willing to ...

TimesSquare Capital Management, an equity investment management company, released its “U.S. Focus Growth Strategy” first-quarter investor letter. A copy of the letter can be downloaded here. In the ...

Legend Biotech (NASDAQ:LEGN) is one of the most promising mid-cap healthcare stocks under $50. As of December 19 closing, the consensus ratings for Legend Biotech (NASDAQ:LEGN) remain bullish. After a ...

Legend Biotech Corporation (NASDAQ:LEGN) is one of the 10 Overlooked Growth Stocks to Buy Now. Legend Biotech Corporation ...